Hero image with Pittsburgh background pittplusme.org/study/1205

Pitt+Me Asteroid: Clinical study in Osteogenesis Imperfecta


STUDY BASICS

Have you been diagnosed with osteogenesis imperfecta (OI)? If so, you may be eligible to participate in a study to help researchers learn the best dosage of a study drug to treat OI. Includes a pre-screening visit where your blood will be drawn and tested to be sure that you have the specific genetic mutation needed to be eligible for the full study.


IRB:
  201704528 - A Phase 2b, Multicentre, Multinational, Placebo-controlled, Double-Blind, Dose-finding Study in Adult Patients with Type I, III or IV Osteogenesis Imperfecta Treated with BPS804

Age Range
AGE:   18 and Up

Location LOCATION: 
UPMC Children’s Hospital of Pittsburgh
Compensation COMPENSATION: 
Travel expenses reimbursed
Phone Number PHONE NUMBER:
1-866-438-8230
I'M INTERESTED
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   FacebookFacebook   TwitterTwitter   Linked-InLinked-In
Search Icon pittplusme.org/study/1205
OR
Phone Number PHONE NUMBER:
1-866-438-8230

PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe facebook twitter

Pitt+Me

This website is maintained by the Clinical and Translational Science Institute.
© Copyright 2018, University of Pittsburgh. All rights reserved.